ArticleFrontiers in pharmacology2021

Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents.

Vu Q Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.